Sean Fahey, a partner in Troutman Pepper Locke’s Health Care + Life Sciences Industry Group, was quoted in the March 11, 2026 Law360 article, “Bayer Sees ‘Light At The End Of The Tunnel’ In Roundup Suits.”

  • “If they get both of those, and frankly, even if they only get one of those, I think you do see the light at the end of the tunnel,” said Sean Fahey, chair of the health care and life sciences department at Troutman Pepper Locke LLP.
  • Troutman’s Fahey said the deal works in part because it provides an opportunity for certainty for plaintiffs but still gives them the right to opt out if they choose.
  • “If for some reason you think your chances are better at trial, then you still have that option,” he said.
Insight Industries + Practices